+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-25Number of Pages: 164

Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing; Application - Infectious Diseases, Oncology, Blood Screening, Microbiology, Genetic Testing, and Women’s Health; End User: Hospitals, Diagnostic Laboratories, Blood Banks, Academics, and Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Global Molecular Diagnostics Market: Snapshot

Molecular diagnostics is an integral part of the in vitro diagnostics industry and has gained an accelerated momentum in recent years. The introduction of tests for Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) and HIV have augmented the demand for PCR technology have completely transformed the earnings of this market over the past two decades. Presently, molecular diagnositcs are extensively used for diagnosing and predicting various genetic disease, hepatitis virus, cancer, and hospital-acquired infections. Furthermore, these kits are also being used for blood donor screening test for HIV and hepatitis. Owing to these reasons, the global molecular diagnostics market is expected to progress at a CAGR of 11.6% between 2016 and 2025. The report states that the global market is expected to be worth US$18.9 bn by the end of 2025 as compared to US$7.1 bn in 2016. 

The research report states that the global molecular diagnostics market is likely to rise against the backdrop of rising pool of the geriatric population, growing demand for personalized health care, and increasing awareness about molecular diagnostics. The market is also expected to grow due to the continuous development in the field of molecular biology. Furthermore, the market is expected to benefit from the increasing investments in research and development of improved molecular diagnostic kits that deliver accurate results. 

molecular diagnostics market

Cost-effective Amplification Offered by Polymerase Chain Reaction Boosts Segment

On the basis of technology, the global molecular diagnostic tests market is segmented into polymerase chain reaction, and Real-Time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others (mass spectrometry etc.). Out of these, the polymerase chain reaction held the largest share in the overall market, accounting for the share of 39.1%in 2016. The robust demand for this technology is attributable to its cost-effectiveness in copying or amplification of small segments of DNA or RNA. During the forecast period, the next generation sequencing segment is anticipated to showcase a rapid growth rate due to its phenomenal throughput, improved speed, and enhanced flexibility, which delivers hundreds of gigabases of data in a single sequencing run. Techniques such as hybridization, microarray, and transcription-mediated amplification are also expected to shine during the forecast period. 

North America Leads Global Market as Consumers Prefer Affordable Testing

On the basis of geography, the global molecular diagnostics market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America held a leading share of 39.1% in the global market. This dominance was due to high prevalence of infectious diseases and rising number of initiatives by governments to raise awareness. Furthermore, the emerging trend of patients opting for molecular diagnostic tests as they are affordable is also contributing to the growth of this regional market. Analysts anticipate that Asia Pacific is also expected to offer several lucrative opportunities to the global market during the forecast period. The demand for molecular diagnostics in Asia Pacific is expected to be propelled by the rising disposable income among the population, growing concerns about health, and improving awareness about molecular diagnostic tests. 

The key players operating in the global molecular diagnostic market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, and Thermo Fisher Scientific Inc. As of 2016, F. Hoffmann-La Roche Ltd dominated the global competitive landscape due to its wide product portfolio and its sprawling presence. The report suggests that Abbott Laboratories followed this lead to be in the second place, while Danaher Corporation ranked number three in the global market.

1. Preface
     1.1. Market definition and scope
     1.2. Market segmentation
     1.3. Key research objectives
     1.4. Research highlights

2. Assumptions and research methodology

3. Executive summary: global molecular diagnostics market

4. Market overview
     4.1. Introduction
             4.1.1. Product definition
     4.2. Market dynamics
             4.2.1. Drivers
                      4.2.1.1. Economic drivers
                      4.2.1.2. Supply side drivers
                      4.2.1.3. Demand side drivers
             4.2.2. Restraints
             4.2.3. Opportunities

5. Global Molecular Diagnostics Market Analysis and Forecast, 2017-2025
     5.1. Market Revenue Projections (US$ Mn)
     5.2. Porter’s Five forces Analysis: Global Molecular Diagnostics Market
     5.3. Future Market Outlook

6. Global Molecular Diagnostics Market Analysis and Forecast, By Technology
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value (US$ Mn) Forecast By Technology
             6.4.1. PCR and Real-Time PCR
             6.4.2. Hybridization
             6.4.3. Microarray
             6.4.4. Transcription-Mediated Amplification
             6.4.5. Next-Generation Sequencing
             6.4.6. Others (Mass Spectrometry etc.)
     6.5. Market Attractiveness By Technology

7. Global Molecular Diagnostics Market Analysis and Forecast, By Application
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value (US$ Mn) Forecast By Application
             7.4.1. Infectious Diseases
                      7.4.1.1. Virology 
                      7.4.1.2. Bacteriology
             7.4.2. Oncology
             7.4.3. Blood Screening
             7.4.4. Microbiology
             7.4.5. Genetic Testing
             7.4.6. Women’s Health
     7.5. Market Attractiveness By Application

8. Global Molecular Diagnostics Market Analysis and Forecasts, By End User
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value (US$ Mn) Forecast By End User
             8.3.1. Hospitals
             8.3.2. Diagnostics Laboratories
             8.3.3. Blood Banks
             8.3.4. Academics & Research
             8.3.5. Others
     8.4. Market Attractiveness By End User

9. Global Molecular Diagnostics Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Value (US$ Mn) Forecast By Region
             9.3.1. North America
             9.3.2. Europe
             9.3.3. Asia Pacific
             9.3.4. Latin America
             9.3.5. Middle East and Africa
     9.4. Market Attractiveness By Region

10. North America Molecular Diagnostics Market Analysis and Forecast
     10.1. Key Findings
     10.2. Policies and Regulations
     10.3. Key Trends
     10.4. Market Value (US$ Mn) Forecast By Technology
             10.4.1. PCR and Real-Time PCR
             10.4.2. Hybridization
             10.4.3. Microarray
             10.4.4. Transcription-Mediated Amplification
             10.4.5. Next-Generation Sequencing
             10.4.6. Others (Mass Spectrometry etc.)
     10.5. Market Value (US$ Mn) and Forecast By Application
             10.5.1. Infectious Diseases
                      10.5.1.1. Virology 
                      10.5.1.2. Bacteriology
             10.5.2. Oncology
             10.5.3. Blood Screening
             10.5.4. Microbiology
             10.5.5. Genetic Testing
             10.5.6. Women’s Health
     10.6. Market Value (US$ Mn) Forecast By End User
             10.6.1. Hospitals
             10.6.2. Diagnostics Laboratories
             10.6.3. Blood Banks
             10.6.4. Academics & Research
             10.6.5. Others
     10.7. Market Value (US$ Mn) Forecast By Country
             10.7.1. U.S.
             10.7.2. Canada
     10.8. Market Attractiveness Analysis 
             10.8.1. By Technology
             10.8.2. By Application
             10.8.3. By End User
             10.8.4. By Country

11. Europe Molecular Diagnostics Market Analysis and Forecast
     11.1. Key Findings
     11.2. Policies and Regulations
     11.3. Key Trends
     11.4. Market Value (US$ Mn) Forecast By Technology
             11.4.1. PCR and Real-Time PCR
             11.4.2. Hybridization
             11.4.3. Microarray
             11.4.4. Transcription-Mediated Amplification
             11.4.5. Next-Generation Sequencing
             11.4.6. Others (Mass Spectrometry etc.)
     11.5. Market Value (US$ Mn) Forecast By Application
             11.5.1. Infectious Diseases
                      11.5.1.1. Virology 
                      11.5.1.2. Bacteriology
             11.5.2. Oncology
             11.5.3. Blood Screening
             11.5.4. Microbiology
             11.5.5. Genetic Testing
             11.5.6. Women’s Health
     11.6. Market Value (US$ Mn) Forecast By End User
             11.6.1. Hospitals
             11.6.2. Diagnostics Laboratories
             11.6.3. Blood Banks
             11.6.4. Academics & Research
             11.6.5. Others
     11.7. Market Value (US$ Mn) Forecast By Country
             11.7.1. Germany
             11.7.2. France
             11.7.3. U.K.
             11.7.4. Italy
             11.7.5. Spain
             11.7.6. Rest of Europe
     11.8. Market Attractiveness Analysis 
             11.8.1. By Technology
             11.8.2. By Application
             11.8.3. By End User
             11.8.4. By Country

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast
     12.1. Key Findings
     12.2. Policies and Regulations
     12.3. Key Trends
     12.4. Market Value (US$ Mn) Forecast By Technology
             12.4.1. PCR and Real-Time PCR
             12.4.2. Hybridization
             12.4.3. Microarray
             12.4.4. Transcription-Mediated Amplification
             12.4.5. Next-Generation Sequencing
             12.4.6. Others (Mass Spectrometry etc.)
     12.5. Market Value (US$ Mn) Forecast By Application
             12.5.1. Infectious Diseases
                      12.5.1.1. Virology 
                      12.5.1.2. Bacteriology
             12.5.2. Oncology
             12.5.3. Blood Screening
             12.5.4. Microbiology
             12.5.5. Genetic Testing
             12.5.6. Women’s Health
     12.6. Market Value (US$ Mn) Forecast By End User
             12.6.1. Hospitals
             12.6.2. Diagnostics Laboratories
             12.6.3. Blood Banks
             12.6.4. Academics & Research
             12.6.5. Others
     12.7. Market Value (US$ Mn) Forecast By Country
             12.7.1. China
             12.7.2. Japan
             12.7.3. Australia
             12.7.4. India
             12.7.5. Rest of Asia Pacific
     12.8. Market Attractiveness Analysis 
             12.8.1. By Technology
             12.8.2. By Application
             12.8.3. By End User
             12.8.4. By Country

13. Latin America Molecular Diagnostics Market Analysis and Forecast
     13.1. Key Findings
     13.2. Policies and Regulations
     13.3. Key Trends
     13.4. Market Value (US$ Mn) Forecast By Technology
             13.4.1. PCR and Real-Time PCR
             13.4.2. Hybridization
             13.4.3. Microarray
             13.4.4. Transcription-Mediated Amplification
             13.4.5. Next-Generation Sequencing
             13.4.6. Others (Mass Spectrometry etc.)
     13.5. Market Value (US$ Mn) Forecast By Application
             13.5.1. Infectious Diseases
                      13.5.1.1. Virology 
                      13.5.1.2. Bacteriology
             13.5.2. Oncology
             13.5.3. Blood Screening
             13.5.4. Microbiology
             13.5.5. Genetic Testing
             13.5.6. Women’s Health
     13.6. Market Value (US$ Mn) Forecast By End User
             13.6.1. Hospitals
             13.6.2. Diagnostics Laboratories
             13.6.3. Blood Banks
             13.6.4. Academics & Research
             13.6.5. Others
     13.7. Market Value (US$ Mn) Forecast By Country
             13.7.1. Brazil
             13.7.2. Mexico
             13.7.3. Rest of Latin America
     13.8. Market Attractiveness Analysis 
             13.8.1. By Technology
             13.8.2. By Application
             13.8.3. By End User
             13.8.4. By Country

14. Middle East and Africa Molecular Diagnostics Market Analysis and Forecast
     14.1. Key Findings
     14.2. Policies and Regulations
     14.3. Key Trends
     14.4. Market Value (US$ Mn) Forecast By Technology
             14.4.1. PCR and Real-Time PCR
             14.4.2. Hybridization
             14.4.3. Microarray
             14.4.4. Transcription-Mediated Amplification
             14.4.5. Next-Generation Sequencing
             14.4.6. Others (Mass Spectrometry etc.)
     14.5. Market Value (US$ Mn) Forecast By Application
             14.5.1. Infectious Diseases
                      14.5.1.1. Virology 
                      14.5.1.2. Bacteriology
             14.5.2. Oncology
             14.5.3. Blood Screening
             14.5.4. Microbiology
             14.5.5. Genetic Testing
             14.5.6. Women’s Health
     14.6. Market Value (US$ Mn) Forecast By End User
             14.6.1. Hospitals
             14.6.2. Diagnostics Laboratories
             14.6.3. Blood Banks
             14.6.4. Academics & Research
             14.6.5. Others
     14.7. Market Value (US$ Mn) Forecast By Country
             14.7.1. Saudi Arabia
             14.7.2. South Africa
             14.7.3. Rest of MEA
     14.8. Market Attractiveness Analysis 
             14.8.1. By Technology
             14.8.2. By Application
             14.8.3. By End User
             14.8.4. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (By Tier and Size of companies)
     15.2. Market Share Analysis By Company (2015)
     15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             15.3.1. Abbott Laboratories
                      15.3.1.1 Company Overview
                      15.3.1.2 Business Overview
                      15.3.1.3 Financial Overview
                      15.3.1.4 SWOT Analysis
                      15.3.1.5 Strategic Overview
             15.3.2. Becton, Dickinson and Company
                      15.3.2.1 Company Overview
                      15.3.2.2 Business Overview
                      15.3.2.3 Financial Overview
                      15.3.2.4 SWOT Analysis
                      15.3.2.5 Strategic Overview
             15.3.3. Bio-Rad Laboratories, Inc.
                      15.3.3.1 Company Overview
                      15.3.3.2 Business Overview
                      15.3.3.3 Financial Overview
                      15.3.3.4 SWOT Analysis
                      15.3.3.5 Strategic Overview
             15.3.4. BioMérieux SA
                      15.3.4.1 Company Overview
                      15.3.4.2 Business Overview
                      15.3.4.3 Financial Overview
                      15.3.4.4 SWOT Analysis
                      15.3.4.5 Strategic Overview
             15.3.5. Danaher Corporation
                      15.3.5.1 Company Overview
                      15.3.5.2 Business Overview
                      15.3.5.3 Financial Overview
                      15.3.5.4 SWOT Analysis
                      15.3.5.5 Strategic Overview
             15.3.6. F. Hoffmann-La Roche Ltd.
                      15.3.6.1 Company Overview
                      15.3.6.2 Business Overview
                      15.3.6.3 Financial Overview
                      15.3.6.4 SWOT Analysis
                      15.3.6.5 Strategic Overview
             15.3.7. QIAGEN N.V.
                      15.3.7.1 Company Overview
                      15.3.7.2 Business Overview
                      15.3.7.3 Financial Overview
                      15.3.7.4 SWOT Analysis
                      15.3.7.5 Strategic Overview
             15.3.8. Siemens AG
                      15.3.8.1 Company Overview
                      15.3.8.2 Business Overview
                      15.3.8.3 Financial Overview
                      15.3.8.4 SWOT Analysis
                      15.3.8.5 Strategic Overview
             15.3.9. Thermo Fisher Scientific Inc.
                      15.3.9.1 Company Overview
                      15.3.9.2 Business Overview
                      15.3.9.3 Financial Overview
                      15.3.9.4 SWOT Analysis
                      15.3.9.5 Strategic Overview

List of Figures 

Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Global Molecular Diagnostics Market Value Share, by Technology (2017)
Figure 3: Global Molecular Diagnostics Market Value Share, by Application (2017)
Figure 4: Global Molecular Diagnostics Market Value Share, by Region (2017)
Figure 5: Global Molecular Diagnostics Market Value Share, by End-user (2017)
Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2025
Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2016
Figure 8: Global PCR and Real-Time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Transcription-Mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2016
Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2025
Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2016
Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2025
Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2016
Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2025
Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2025
Figure 37: North America Market Attractiveness Analysis, by Technology
Figure 38: North America Market Attractiveness Analysis, by Application
Figure 39: North America Market Attractiveness Analysis, by End-user
Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2025
Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2025
Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2025
Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology
Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application
Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user
Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2025
Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2025
Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology
Figure 56: Asia Pacific Market Attractiveness Analysis, by Application
Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2025
Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2025
Figure 64: Latin America Market Attractiveness Analysis, by Technology
Figure 65: Latin America Market Attractiveness Analysis, by Application
Figure 66: Latin America Market Attractiveness Analysis, by End-user
Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis By Country, 2016
Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2025
Figure 71: Middle East & Africa Market Value Share Analysis, by End User, 2017 and 2025
Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2025
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology
Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 75: Middle East & Africa Market Attractiveness Analysis, by End User
Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company

List of Tables

Table 1: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025 
Table 2: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 3: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 4: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 5: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Application, 2015–2025
Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Infectious Diseases, 2015–2025
Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2025
Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025

Global Molecular Diagnostics Market: Overview

This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market. The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis. 

Global Molecular Diagnostics Market: Segmentation

Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women’s health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report. 

Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. 

Global Molecular Diagnostics Market: Regional Outlook

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions:   North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market. 

Key Players Mentioned in this Report are:

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.

The global molecular diagnostics market is segmented as given below:

Global Molecular Diagnostics Market, by Technology

  • PCR and Real-Time PCR
  • Hybridization
  • Microarray
  • Transcription-Mediated Amplification
  • Next-Generation Sequencing
  • Others (Mass Spectrometry, etc.)

Global Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women’s Health

Global Molecular Diagnostics Market, by End Use

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics
  • Research

Global Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top